257 related articles for article (PubMed ID: 24927902)
1. A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival.
Hou Z; Zhao W; Zhou J; Shen L; Zhan P; Xu C; Chang C; Bi H; Zou J; Yao X; Huang R; Yu L; Yan J
Int J Biochem Cell Biol; 2014 Aug; 53():380-8. PubMed ID: 24927902
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer.
Saghaeian Jazi M; Samaei NM; Ghanei M; Shadmehr MB; Mowla SJ
Tumour Biol; 2016 Aug; 37(8):10329-38. PubMed ID: 26846097
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
4. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
[TBL] [Abstract][Full Text] [Related]
6. Identification of new SOX2OT transcript variants highly expressed in human cancer cell lines and down regulated in stem cell differentiation.
Saghaeian Jazi M; Samaei NM; Ghanei M; Shadmehr MB; Mowla SJ
Mol Biol Rep; 2016 Feb; 43(2):65-72. PubMed ID: 26703382
[TBL] [Abstract][Full Text] [Related]
7. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.
Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y
Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression.
Sun Y; Jin SD; Zhu Q; Han L; Feng J; Lu XY; Wang W; Wang F; Guo RH
Oncotarget; 2017 Apr; 8(17):28297-28311. PubMed ID: 28423699
[TBL] [Abstract][Full Text] [Related]
11. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Fang J; Sun CC; Gong C
Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SOX2OT affects cervical cancer cell growth, migration and invasion by regulating SOX2.
Chang X; Zhang H; Yang Q; Pang L
Cell Cycle; 2020 Jun; 19(11):1391-1403. PubMed ID: 32286144
[TBL] [Abstract][Full Text] [Related]
15. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
[TBL] [Abstract][Full Text] [Related]
17. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
18. The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2.
Li Z; Xu L; Tang N; Xu Y; Ye X; Shen S; Niu X; Lu S; Chen Z
FEBS Lett; 2014 Aug; 588(17):3000-7. PubMed ID: 24928441
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.
Huqun ; Ishikawa R; Zhang J; Miyazawa H; Goto Y; Shimizu Y; Hagiwara K; Koyama N
Cancer; 2012 Mar; 118(6):1599-606. PubMed ID: 21837672
[TBL] [Abstract][Full Text] [Related]
20. NSPc1 polycomb protein complex binds and cross‑talks to lncRNAs in glioma H4 cells.
Wang Y; Liang Z; Li H; Tao J; Sun Y; Gong Y
Oncol Rep; 2019 Apr; 41(4):2575-2584. PubMed ID: 30720120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]